Mario Ceravolo
About Mario Ceravolo
Mario Ceravolo is the Finance Director Italy at Bristol Myers Squibb, based in Roma, Lazio, Italia. He has held various finance-related roles at the company and previously worked at Deloitte & Touche as a Supervisor Auditor.
Title
Mario Ceravolo holds the position of Finance Director Italy at Bristol Myers Squibb, based in Roma, Lazio, Italia. In this role, he manages financial operations, including budgeting, forecasting, and financial oversight.
Current Role at Bristol Myers Squibb
Currently, Mario Ceravolo serves as the Finance Director Italy at Bristol Myers Squibb. His responsibilities include budgeting and forecasting legal entity results, overseeing treasury and cash flow management, and leading the business control function area. Mario also handles the order-to-cash process, which includes customer service, master data, credit, and collections.
Previous Positions at Bristol Myers Squibb
Before becoming the Finance Director Italy, Mario held several roles at Bristol Myers Squibb, including Interim Head of Finance Nordics for 7 months in 2020 and Country Controller - Italy from 2018 to 2021. Additionally, he worked as Chief Accountant from 2015 to 2018. These roles equipped him with extensive experience in finance management and leadership within the company.
Career at Deloitte & Touche
From 2008 to 2014, Mario Ceravolo worked at Deloitte & Touche as a Supervisor Auditor in Rome. Over six years, he developed a strong foundation in auditing, further solidifying his expertise in financial oversight and management.
Education and Expertise
Mario Ceravolo holds a Master's degree in Economics from the University of Rome Tor Vergata, achieved between 2002 and 2007. He also studied at Evtek, completing a bachelor's degree in 2006. His academic background in economics provides a solid foundation for his roles in finance and management.
Leadership and Board Memberships
Mario is a member of the Compliance Committee at Bristol Myers Squibb Italy and part of the Major Markets Finance Leadership Team. He also serves on the Board of Directors for both Bristol Myers Squibb and Celgene Italy, contributing his expertise to strategic decision-making and governance.